Healthcare provider profile · identity verified

Eric D Blakney, MD

Allopathic & Osteopathic Physicians|Internal Medicine · MEMPHIS, TN · NPI 1912909508

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Eric D Blakney, MD received $135.86 in general payments during 2025 across 2 reported records.

Edwards Lifesciences Corporation accounted for 80.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Entresto by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$135.86

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Edwards Lifesciences Corporation	Unresolved — no canonical attribution shown	$109.09	80.3%	1	2025
Novartis Pharmaceuticals Corporation	Unresolved — no canonical attribution shown	$26.77	19.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$135.86	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia	Device	Edwards Lifesciences Corporation	$109.09	1	2025
Source payment records 2025-04-16 · Edwards Lifesciences Corporation · $109.09 · Open Payments source
LEQVIO Normalized: leqvio	Drug	Novartis Pharmaceuticals Corporation	$26.77	1	2025
Source payment records 2025-01-09 · Novartis Pharmaceuticals Corporation · $26.77 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference	2025	ENTRESTO open payments reported associated product	CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797	Entresto · 2024 Exact normalized brand match · 1 Part D row	15	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	771	260
Atorvastatin Calcium	Atorvastatin Calcium	582	201
Gabapentin	Gabapentin	431	99
Pantoprazole Sodium	Pantoprazole Sodium	310	116
Losartan Potassium	Losartan Potassium	266	94
Metoprolol Succinate	Metoprolol Succinate	210	60
Hydralazine Hcl	Hydralazine Hcl	208	69
Omeprazole	Omeprazole	200	56
Levothyroxine Sodium	Levothyroxine Sodium	188	62
Metformin Hcl	Metformin Hcl	183	60
Potassium Chloride	Potassium Chloride	183	66
Rosuvastatin Calcium	Rosuvastatin Calcium	182	64
Allopurinol	Allopurinol	172	53
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	165	56
Tamsulosin Hcl	Tamsulosin Hcl	164	51
Metoprolol Tartrate	Metoprolol Tartrate	154	53
Carvedilol	Carvedilol	151	52
Furosemide	Furosemide	150	61
Simvastatin	Simvastatin	141	39
Albuterol Sulfate Hfa	Albuterol Sulfate	133	67
Trazodone Hcl	Trazodone Hcl	132	28
Donepezil Hcl	Donepezil Hcl	131	30
Januvia	Sitagliptin Phosphate	127	30
Hydrochlorothiazide	Hydrochlorothiazide	123	43
Lisinopril	Lisinopril	123	42
Pravastatin Sodium	Pravastatin Sodium	120	34
Jardiance	Empagliflozin	113	23
Alendronate Sodium	Alendronate Sodium	112	33
Clopidogrel	Clopidogrel Bisulfate	110	44
Montelukast Sodium	Montelukast Sodium	108	43
Eliquis	Apixaban	103	28
Tizanidine Hcl	Tizanidine Hcl	101	24
Clonidine Hcl	Clonidine Hcl	99	35
Baclofen	Baclofen	95	30
Glimepiride	Glimepiride	95	31
Fluticasone Propionate	Fluticasone Propionate	94	60
Pregabalin	Pregabalin	91	20
Famotidine	Famotidine	83	29
Metformin Hcl Er	Metformin Hcl	83	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	77	22
Memantine Hcl	Memantine Hcl	74	21
Meloxicam	Meloxicam	73	24
Citalopram Hbr	Citalopram Hydrobromide	68	14
Ozempic	Semaglutide	68	20
Mirtazapine	Mirtazapine	66	21
Alprazolam	Alprazolam	64	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	63	18
Levetiracetam	Levetiracetam	61	16
Methylprednisolone	Methylprednisolone	61	47
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	59	43
Atenolol	Atenolol	58	15
Escitalopram Oxalate	Escitalopram Oxalate	58	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	16
Spironolactone	Spironolactone	54	17
Tramadol Hcl	Tramadol Hcl	53	21
Glipizide	Glipizide	51	15
Risperidone	Risperidone	51	16
Ibuprofen	Ibuprofen	50	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	15
Zolpidem Tartrate	Zolpidem Tartrate	46	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	45	19
Duloxetine Hcl	Duloxetine Hcl	44	15
Mupirocin	Mupirocin	44	24
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Azithromycin	Azithromycin	41	33
Triamcinolone Acetonide	Triamcinolone Acetonide	40	27
Diclofenac Sodium	Diclofenac Sodium	38	15
Meclizine Hcl	Meclizine Hcl	37	22
Amitriptyline Hcl	Amitriptyline Hcl	36	11
Cefdinir	Cefdinir	36	32
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	11
Amiodarone Hcl	Amiodarone Hcl	35	suppressed
Fluconazole	Fluconazole	35	21
Hydroxyzine Hcl	Hydroxyzine Hcl	35	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	35	11
Terazosin Hcl	Terazosin Hcl	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Divalproex Sodium	Divalproex Sodium	34	suppressed
Enalapril Maleate	Enalapril Maleate	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Prednisone	Prednisone	34	13
Warfarin Sodium	Warfarin Sodium	34	suppressed
Myrbetriq	Mirabegron	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	27
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Promethazine Hcl	Promethazine Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Finasteride	Finasteride	31	12
Benazepril Hcl	Benazepril Hcl	30	13
Naproxen	Naproxen	30	11
Farxiga	Dapagliflozin Propanediol	29	suppressed
Lorazepam	Lorazepam	29	17
Mounjaro	Tirzepatide	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Cephalexin	Cephalexin	28	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Nifedipine Er	Nifedipine	28	14
Sertraline Hcl	Sertraline Hcl	28	11
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	11
Buspirone Hcl	Buspirone Hcl	25	suppressed
Levofloxacin	Levofloxacin	25	16
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Methocarbamol	Methocarbamol	24	14
Janumet Xr	Sitagliptin Phos/Metformin Hcl	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Rybelsus	Semaglutide	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	23	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Colchicine	Colchicine	21	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Calcitriol	Calcitriol	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Valsartan	Valsartan	19	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Lactulose	Lactulose	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Diazepam	Diazepam	17	suppressed
Kerendia	Finerenone	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Desmopressin Acetate	Desmopressin Acetate	14	suppressed
Linzess	Linaclotide	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	13
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Digoxin	Digoxin	12	suppressed
Donepezil Hcl Odt	Donepezil Hcl	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Propafenone Hcl	Propafenone Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Nystatin	Nystatin	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$135.86 · 2 records	Edwards Lifesciences Corporation	LEQVIO, SAPIEN 3 Ultra RESILIA	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Novartis Pharmaceuticals Corporation?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error